SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0700+1.4%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Khris Smith11/23/2012 4:29:24 PM
  Read Replies (1) of 13111
 
biz.yahoo.com

Form 8-K for PROVECTUS PHARMACEUTICALS INC 23-Nov-2012

Other Events


Item 8.01. Other Events. On November 21, 2012, Provectus Pharmaceuticals, Inc., a Nevada corporation (the "Company"), was made aware, after the stock market closed, that the law firm of Levi & Korsinsky, LLP, is seeking information in connection with the compensation paid to the Company's executive officers.

The Company has received no inquiry from the staff of the U.S. Securities and Exchange Commission (the "SEC") related to this matter. The Company has received no inquiry from Nasdaq or any other self-regulatory organization related to this matter. The Company has never received shareholder proposals related to compensation.

The Company held its most recent annual meeting of stockholders on Thursday, June 28, 2012. The Company's stockholders approved the advisory vote on the compensation of the Company's named executive officers.

The Company may take legal action to recoup expenses relating to this matter and to determine if stock manipulation, including possible shorting in the Company's stock, has occurred due to the actions of Levi & Korsinsky.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext